European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes by Country

In 2023, European healthcare expenditure on pharmaceuticals and medical non-durable goods by government schemes showed notable variations. Malta leads with significant growth at 33.93% year-on-year, driving its expenditure to 2.93% of GDP. Italy, Spain, and Portugal also witnessed moderate increases, while Estonia experienced a remarkable surge of 48.96%. Conversely, countries like Ireland and France posted notable declines. Germany’s expenditure growth is notable with a substantial 19.42% increase. Stable expenditure in regions such as the Netherlands and Luxembourg suggests a leveling trend.

Looking forward, European countries should monitor the impact of demographics, innovation, and economic fluctuations on healthcare budgets. The focus will likely shift to sustainable expenditure growth, cost-efficiency, and addressing demographic challenges through strategic healthcare planning and innovative treatments. Maintaining or improving GDP percentage allocations for healthcare will be crucial in adapting to these evolving factors.